About Veravas
At Veravas, our leadership team brings together decades of experience across healthcare, biotechnology, and global operations. Their expertise drives innovation, growth, and success in delivering breakthrough technologies to market.
Our Leadership Team
John Forrest
Co-Founder, CEO, & Executive Chairman
Mr. Forrest is a seasoned entrepreneur with over 30 years of experience in healthcare IT, innovation, and commercializing advanced technologies. He has successfully led multiple ventures recognized for fast growth, including Leading Inc. 500 Fastest Growing Companies, and is a Stevie Award Winner.
Josh Soldo
Chief Scientific Officer & Co-Founder
Mr. Soldo, the inventor of VeraBIND technology, has over 25 years of experience in diagnostics and commercialization. He holds numerous patents and has brought multiple breakthrough products to market, generating billions in revenue. His leadership spans from Beckman Coulter to Diasorin and Roche.
Luc Vanhal
Chief Operating Officer
Mr. Vanhal is a global leader in operations and finance with a proven track record in steering emerging and publicly traded companies. His background includes managing operations for consumer brands such as Walt Disney Consumer Products, Activision/Blizzard, Synergy CHC, and Guthy Renker.
Chris Mirro
Mr. Mirro is a seasoned executive with over 30 years of healthcare experience, leading billion-dollar growth initiatives across services, technology, and consulting. He has held key leadership roles at organizations such as Maximus, Accenture, and ACS.
Scientific Advisory Board
Khalid Iqbal, PhD
Professor of Neuroscience & Chairman at the New York State Institute
Henrik Zetterberg, MD, PhD
Professor & Chief Physician at University of Gothenburg, Sweden
Charlotte Teunissen, PhD
Michael Weiner, PhD
Professor at University of California San Francisco (UCSF)
Giulio M Pasinetti, MD, PhD
Saunders Family Chair & Professor of Neurology at the Icahn School of Medicine at Mount Sinai